Dr. Gil Van Bokkelen

Dr. Gil Van Bokkelen is the Chairman and CEO of Athersys, Inc. (NASDAQ: ATHX), a biopharmaceutical company based in Cleveland, Ohio.  He has served as Chairman of the Board of Directors at Athersys since August 2000, and as CEO since the company was formed, overseeing the growth and development of the primary business operations at the company and the transition from a venture backed start-up to a NASDAQ listed public company. He also serves as Chairman of the National Center for Regenerative Medicine. Dr. Van Bokkelen received his Ph.D. in Genetics from Stanford University School of Medicine and earned degrees in both Economics and Molecular Biology at the University of California at Berkeley.